Aficamten shows promise in enhancing exercise capacity in patients with hypertrophic cardiomyopathy

FHS
May 13, 2024
6:54 pm

Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised with limiting symptoms such as exertional dyspnoea and decreased exercise capacity.

Safety Intelligence is Redefining How Pharmacovigilance Teams Operate

Beena Wood, Senior VP of Product Management, Safety and Medical Affairs, ArisGlobal The future of safety intelligence is now. New safety reporting and analytics advancements

August 3, 2023

Cancer Treatment Ups CV Risk; Therapy’s Next Big Thing; Nude Photos Settlement

Older adults treated for cancer had double the risk of cardiovascular (CV) events, including stroke, as compared with those without cancer, emphasizing the need for

September 27, 2024

RUSH Adopts Suki AI Assistant to Reduce Clinician Burnout

What You Should Know: Suki, the leader in voice artificial intelligence (AI) technology for healthcare, today announced that RUSH University System for Health, an academic health

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.